Home » Topics » Disease categories and therapies » Immune

Immune
RSS

BTG licenses anti-CD3 antibody to LeukoSite

March 15, 1999

FDA grants fast track designation for pneumococcal conjugate vaccine

March 12, 1999

Zenapax shows positive results in GVHD trial

March 10, 1999

North American Vaccine adds new product to R&D pipeline; U.S. patent issues

March 8, 1999

Licensing opportunity from BTG: fatty acid-peptide conjugates for use in vaccines

March 5, 1999

Epicoat technology granted U.S. patent protection

March 5, 1999

Roche obtains European marketing approval for transplant drug

March 4, 1999

Novel vaccine technology available for licensing from BTG

March 4, 1999

Praxis purchases intellectual property allowing development of antirejection drug

March 4, 1999

Cerus cleared by FDA to begin clinical trials of transplantation system

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...